Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$34.26

-2.46 (-6.70%)

, UNH

UnitedHealth

$160.72

2.4 (1.52%)

12:43
12/01/16
12/01
12:43
12/01/16
12:43

UnitedHealth policy for Exondys 51 a positive for Sarepta, says Credit Suisse

Credit Suisse analyst Alethia Young noted that Sarepta (SRPT) shares have been weak since UnitedHealth (UNH) posted its medical benefit policy for the company's DMD drug Exondys 51, but she doesn't see a reason for the weakness. She doesn't think encouraging home infusions limits access and believes the requirement for an every 6 month reauthorization is neither "prohibitive nor concerning" as it is standard with expensive rare disease treatments. She sees the policy as a positive for Sarepta, as having more payers supporting Exondys reimbursement makes it hard for other payers not to do so, and keeps an Outperform rating on Sarepta shares.

SRPT

Sarepta

$34.26

-2.46 (-6.70%)

UNH

UnitedHealth

$160.72

2.4 (1.52%)

SRPT Sarepta
$34.26

-2.46 (-6.70%)

10/27/16
WEDB
10/27/16
NO CHANGE
Target $72
WEDB
Outperform
Sarepta selloff overdone, says Wedbush
Wedbush analyst Heather Behanna said the selloff in Sarepta is overdone and recommends shares ahead of the Exondys 51 launch update in January. The analyst has an Outperform rating and a $72 price target on Sarepta shares.
11/11/16
LEER
11/11/16
NO CHANGE
Target $55
LEER
Market Perform
Sarepta Exondys 51 launch expectations seem too high for 2017, says Leerink
Leerink analyst Joseph Schwartz believes Sarepta Exondys 51 launch expectations may be too high for 2017. While nothing that a true Duchenne muscular dystrophy prevalence remains unknown, the analyst says that a "start form" number of about 200 patients would need to be provided in early January in order for investors to be confident in 2017 consensus sales estimates of $215M. Additionally, Schwartz points out that based on the price of Exondys 51 per vial, it currently appears that management has underestimated the true price of the drug which they will realize.
11/29/16
BARD
11/29/16
NO CHANGE
Target $102
BARD
Outperform
Baird sees strong launch for Sarepta after surveying neurologists
After his firm surveyed 30 neurologists treating at least ten Duchenne muscular dystrophy patients and at least five suspected/confirmed patients amenable to exon-51 skipping, Baird analyst Brian Skorney believes Sarepta Therapeutics' Exondys 51 is positioned for a strong launch. In a research note earlier today, Skorney said that most of the 30 doctors surveyed seem convinced of the drug's efficacy, and plan to start prescribing the drug in the next year. The drug's consensus sales estimate for its first quarter on the market of $7.1M may be understating sales, Skorney wrote. The analyst continues to expect $11M of Exondys 51 sales in Q4. He has an Outperform rating on shares of Sarepta with a $102 price target. The stock is up 34c, or 1%, to $36.62 in morning trading.
12/01/16
RBCM
12/01/16
NO CHANGE
RBCM
Outperform
Sarepta DMD drug still likely to be covered by UnitedHealth, says RBC Capital
RBC Capital analyst Simos Simeonidis said some language in UnitedHealthcare's (UNH) Commercial Drug Policy for Sarepta's (SRPT) Exondys 51 may have "spooked" investors, but he continues to believe that the DMD drug will end up being covered by the insurer. The analyst, who would be a buyer of Sarepta amid this weakness, keeps an Outperform rating on the stock.
UNH UnitedHealth
$160.72

2.4 (1.52%)

11/30/16
UBSW
11/30/16
NO CHANGE
Target $193
UBSW
Buy
UnitedHealth price target raised to $193 from $180 at UBS
UBS analyst A.J. Rice raised his price target on UnitedHealth to $193 from $180 following its very positive investor day. The company said they see strong growth driven by both group and individual markets while controlling their commercial medical cost trend, noted Rice, who reiterated his Buy rating on UnitedHealth shares.
11/30/16
COWN
11/30/16
NO CHANGE
Target $175
COWN
Outperform
UnitedHealth price target raised to $175 from $150 at Cowen
Cowen analyst Christine Arnold raised her price target on UnitedHealth to $175 from $150 reflecting the company's guidance provided at its analyst day.The analyst said UnitedHealth remains a top pick for 2017 as it has an abundance of tailwinds and minimal company-specific headwinds. Arnold reiterated her Outperform rating on UnitedHealth shares.
11/30/16
SBSH
11/30/16
NO CHANGE
Target $178
SBSH
Buy
UnitedHealth price target raised to $178 after analyst day at Citi
Citi analyst Ralph Giacobbe said UnitedHealth's "upbeat tone" at its investor day matched the company's "impressive" 2017 guidance, saying the company remains in an enviable position of having size, scale, and infrastructure to invest while expanding its reach via Optum. Giacobbe raised his price target on UnitedHealth shares to $178 from $164 and keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

02:45
02/24/17
02/24
02:45
02/24/17
02:45
General news
FX Action: The dollar has been in consolidation »

FX Action: The dollar has…

HL

Hecla Mining

$6.07

-0.29 (-4.56%)

21:32
02/23/17
02/23
21:32
02/23/17
21:32
Upgrade
Hecla Mining rating change  »

Hecla Mining upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

RIG

Transocean

$14.31

1.03 (7.76%)

21:31
02/23/17
02/23
21:31
02/23/17
21:31
Downgrade
Transocean rating change  »

Transocean downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CYOU

Changyou.com

$27.47

-0.56 (-2.00%)

21:30
02/23/17
02/23
21:30
02/23/17
21:30
Upgrade
Changyou.com rating change  »

Changyou.com upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOUR

Tuniu

$8.51

-0.2 (-2.30%)

21:30
02/23/17
02/23
21:30
02/23/17
21:30
Upgrade
Tuniu rating change  »

Tuniu upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFUN

Fang Holdings

$3.00

-0.02 (-0.66%)

21:30
02/23/17
02/23
21:30
02/23/17
21:30
Downgrade
Fang Holdings rating change  »

Fang Holdings downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YY

YY

$45.72

-1.16 (-2.47%)

21:29
02/23/17
02/23
21:29
02/23/17
21:29
Downgrade
YY rating change  »

YY downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUN

Sunoco

$27.56

-0.22 (-0.79%)

21:26
02/23/17
02/23
21:26
02/23/17
21:26
Downgrade
Sunoco rating change  »

Sunoco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

QUNR

Qunar

$30.39

-0.22 (-0.72%)

20:25
02/23/17
02/23
20:25
02/23/17
20:25
Conference/Events
Qunar to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

COG

Cabot Oil & Gas

$22.53

-0.07 (-0.31%)

, FL

Foot Locker

$68.58

-2.44 (-3.44%)

20:25
02/23/17
02/23
20:25
02/23/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

COG

Cabot Oil & Gas

$22.53

-0.07 (-0.31%)

FL

Foot Locker

$68.58

-2.44 (-3.44%)

JCP

J.C. Penney

$6.86

-0.19 (-2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 24

    Feb

IIPR

Innovative Industrial Properties

$18.05

0.05 (0.28%)

20:04
02/23/17
02/23
20:04
02/23/17
20:04
Hot Stocks
White House: Likely to see 'greater enforcement' of federal marijuana laws »

During a press briefing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$136.53

-0.58 (-0.42%)

, SMCI

Super Micro Computer

$27.40

0.3 (1.11%)

19:55
02/23/17
02/23
19:55
02/23/17
19:55
Periodicals
Apple cut ties to Super Micro over security concerns, The Information says »

Apple (AAPL) terminated…

AAPL

Apple

$136.53

-0.58 (-0.42%)

SMCI

Super Micro Computer

$27.40

0.3 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 13

    Mar

HLF

Herbalife

$59.40

-1.34 (-2.21%)

19:45
02/23/17
02/23
19:45
02/23/17
19:45
Hot Stocks
Herbalife says board approves new $1.5B repurchase plan »

In its Q4 earnings report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

AHT

Ashford Hospitality

$7.37

-0.13 (-1.73%)

19:17
02/23/17
02/23
19:17
02/23/17
19:17
Earnings
Ashford Trust reports Q4 AFFO 16c, may not compare to consensus (32c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

PG

Procter & Gamble

$91.13

-0.31 (-0.34%)

, EPC

Edgewell Personal Care

$76.27

-5.44 (-6.66%)

19:13
02/23/17
02/23
19:13
02/23/17
19:13
Hot Stocks
Procter & Gamble says cutting Gillette prices by double digits »

Speaking during the…

PG

Procter & Gamble

$91.13

-0.31 (-0.34%)

EPC

Edgewell Personal Care

$76.27

-5.44 (-6.66%)

UL

Unilever; also tag UN

$46.90

-0.03 (-0.06%)

UN

Unilever; also tag UL

$46.58

-0.17 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 19

    Mar

NSU

Nevsun Resources

$2.94

-0.06 (-2.00%)

19:12
02/23/17
02/23
19:12
02/23/17
19:12
Hot Stocks
Nevsun Resources redeploys $120M to fund Timok »

Nevsun announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSU

Nevsun Resources

$2.94

-0.06 (-2.00%)

19:11
02/23/17
02/23
19:11
02/23/17
19:11
Hot Stocks
Nevsun plans to drill over 130,000 meters during 2017 across 3 countries »

The company is planning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSU

Nevsun Resources

$2.94

-0.06 (-2.00%)

19:10
02/23/17
02/23
19:10
02/23/17
19:10
Hot Stocks
Nevsun sees Bisha processing 2.4M tonnes of primary one in FY17 »

Nevsun expects Bisha to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSU

Nevsun Resources

$2.94

-0.06 (-2.00%)

19:10
02/23/17
02/23
19:10
02/23/17
19:10
Hot Stocks
Nevsun sees investing $45M at Timok Upper Zone Project in FY17 »

The company expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSU

Nevsun Resources

$2.94

-0.06 (-2.00%)

19:08
02/23/17
02/23
19:08
02/23/17
19:08
Earnings
Nevsun reports FY16 EPS 4c, consensus 7c »

Reports FY16 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBF

SoftBank

$76.88

-0.02 (-0.03%)

, S

Sprint

$8.96

-0.33 (-3.55%)

19:01
02/23/17
02/23
19:01
02/23/17
19:01
Hot Stocks
SoftBank, Sprint, TBCASoft partner in blockchain technology for telecoms »

SoftBank (SFTBF), Sprint…

SFTBF

SoftBank

$76.88

-0.02 (-0.03%)

S

Sprint

$8.96

-0.33 (-3.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 06

    Mar

GOOG

Alphabet

$831.33

0.57 (0.07%)

, GOOGL

Alphabet Class A

$851.00

-0.36 (-0.04%)

18:59
02/23/17
02/23
18:59
02/23/17
18:59
Periodicals
Alphabet's Waymo sues Uber for allegedly stealing trade secrets, Bloomberg says »

Alphabet's Waymo…

GOOG

Alphabet

$831.33

0.57 (0.07%)

GOOGL

Alphabet Class A

$851.00

-0.36 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 06

    Mar

  • 19

    Mar

ALB

Albemarle

$92.41

-0.03 (-0.03%)

18:57
02/23/17
02/23
18:57
02/23/17
18:57
Hot Stocks
Albemarle raises quarterly dividend 5% to 32c from 30.5c per share »

The dividend, which has a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 16

    Mar

UTX

United Technologies

$112.09

-0.57 (-0.51%)

18:32
02/23/17
02/23
18:32
02/23/17
18:32
Hot Stocks
Carrier expands air conditioner, heat pump recall »

United Technologies'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

BREW

Craft Brew

$15.60

-0.25 (-1.58%)

, BUD

AB InBev

$108.76

-0.4 (-0.37%)

18:17
02/23/17
02/23
18:17
02/23/17
18:17
Hot Stocks
Craft Brew reschedules Q4 report to allow additional time for audit »

Craft Brew Alliance…

BREW

Craft Brew

$15.60

-0.25 (-1.58%)

BUD

AB InBev

$108.76

-0.4 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.